Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $31.00
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target increased by Bank of America from $29.00 to $31.00 in a report issued on Tuesday,Benzinga reports. Bank of America currently has a ...
The Manila Times22 小时
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of ...